BGM
Overvalued by 90.8% based on the discounted cash flow analysis.
Market cap | $38.68 Million |
---|---|
Enterprise Value | $32.81 Million |
Dividend Yield | $0 (-%) |
Earnings per Share | $- |
Beta | 1.44 |
Outstanding Shares | - |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | - |
---|---|
PEG | - |
Price to Sales | - |
Price to Book Ratio | - |
Enterprise Value to Revenue | 0.35 |
Enterprise Value to EBIT | -20.13 |
Enterprise Value to Net Income | -6 |
Total Debt to Enterprise | 0.05 |
Debt to Equity | 0.04 |
No data
No data
Qilian International Holding Group Limited, headquartered in Gansu, China, is a pharmaceutical and chemical products manufacturer in China. It focuses on the development, manufacture, marketing and sale of licorice products, oxytetracycl...